Amylyx Pharmaceuticals Inc (AMLX) financials · $561.6M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Amylyx Pharmaceuticals Inc (AMLX) $561.6M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | N/A | $87.4M |
| Cost of Revenue | N/A | $5.95M |
| Gross Profit | N/A | $81.4M |
| Operating Income | -$153.3M | -$314.7M |
| Net Income | -$144.7M | -$301.7M |
| EPS (Diluted) | -$1.53 | -$4.43 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $332.6M | $193.6M |
| Current Assets | $323.7M | $189.4M |
| Cash & Equivalents | $226.7M | $77.4M |
| PP&E | $310.0K | $961.0K |
| Total Liabilities | $27.4M | $28.9M |
| Current Liabilities | $22.7M | $28.4M |
| Shareholders' Equity | $305.3M | $164.8M |
| Retained Earnings | -$751.4M | -$606.7M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$123.3M | -$167.6M |
| CapEx | $138.0K | $157.0K |
| Investing Cash Flow | $14.0M | $75.7M |
| Financing Cash Flow | $257.0M | $348.0K |
| Net Change in Cash | $148.8M | -$92.1M |
| Free Cash Flow | -$123.5M | -$167.8M |
FAQ
What is AMLX P/E and revenue?
Amylyx Pharmaceuticals Inc (AMLX) $561.6M cap.
What is AMLX revenue?
AMLX income-statement cache has no revenue figure yet.
Is AMLX profitable?
Amylyx Pharmaceuticals Inc last cached net income is -$144.7M (FY2025).
What are AMLX total assets?
Amylyx Pharmaceuticals Inc last cached total assets are $332.6M (FY2025).
What is AMLX free cash flow?
Amylyx Pharmaceuticals Inc last cached free cash flow is -$123.5M (FY2025).
Not investment advice. Cached statements, not a live tape.